Por favor, use este identificador para citar o enlazar este ítem: https://repositorio.uca.edu.ar/handle/123456789/1467
Campo DC Valor Lengua/Idioma
dc.contributor.authorPandi Perumal, Seithikurippu R.es
dc.contributor.authorBaHammam, Ahmed S.es
dc.contributor.authorOjike, Nwakile I.es
dc.contributor.authorAkinseye, Oluwaseunes
dc.contributor.authorKendzerska, Tetyanaes
dc.contributor.authorButtoo, Kennethes
dc.contributor.authorDhandapany, Perundurai S.es
dc.contributor.authorBrown, Gregory M.es
dc.contributor.authorCardinali, Daniel Pedroes
dc.date.accessioned2019-05-02T13:56:21Z-
dc.date.available2019-05-02T13:56:21Z-
dc.date.issued2017-
dc.identifier.citationPandi-Perumal, S. R., et al. Melatonin and human cardiovascular disease [en línea]. Preprint del documento publicado en Journal of Cardiovascular Pharmacology and Therapeutics. 2017, 22 (2). doi: 10.1177/1074248416660622. Disponible en: https://repositorio.uca.edu.ar/handle/123456789/1467es
dc.identifier.issn1940-4034 (en línea)-
dc.identifier.urihttps://repositorio.uca.edu.ar/handle/123456789/1467-
dc.description.abstractAbstract: The possible therapeutic role of melatonin in the pathophysiology of coronary artery disorder (CAD) is increasingly being recognized. In humans, exogenous melatonin has been shown to decrease nocturnal hypertension, improve systolic and diastolic blood pressure, reduce the pulsatility index in the internal carotid artery, decrease platelet aggregation and reduce serum catecholamine levels. Low circulating levels of melatonin are reported in individuals with CAD, arterial hypertension and congestive heart failure. This review assesses current literature on the cardiovascular effects of melatonin in humans. It can be concluded that melatonin deserves to be considered in clinical trials evaluating novel therapeutic interventions for cardiovascular disorders.es
dc.formatapplication/pdfes
dc.languageenges
dc.language.isoenges
dc.publisherSAGE Publicationses
dc.rightsAcceso Abiertoes
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/es
dc.sourcePreprint del documento publicado en Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 22, N° 2, 2017es
dc.subjectMEDICINAes
dc.subjectMELATONINAes
dc.subjectPRESION SANGUINEAes
dc.subjectENFERMEDADES CARDIOVASCULARESes
dc.subjectHIPERTENSIONes
dc.titleMelatonin and human cardiovascular diseasees
dc.typeArtículoes
uca.pathFacultad de Ciencias Médicas|Instituto de Investigaciones Biomédicas (BIOMED UCA-CONICET)es
uca.disciplinaMEDICINAes
uca.filename/home/data-uca-generic/folder_generic/IIBiomedicas/melatonin-human-cardiovascular-disease/metadata.xmles
uca.issnrd1es
uca.affiliationFil: Pandi Perumal, Seithikurippu R. King Saud University. College of Medicine. Departament of Medicina. The University Sleep Disorders Center; Saudi Arabiaes
uca.affiliationFil: BaHammam, Ahmed S. King Saud University. College of Medicine. Departament of Medicina. The University Sleep Disorders Center; Saudi Arabiaes
uca.affiliationFil: Ojike, Nwakile I. New York University Medical Center. Department of Population Health. Division of Health and Behavior. Center for Healthful Behavior Change; Estados Unidoses
uca.affiliationFil: Akinseye, Oluwaseun. Queens Hospital Center. Icahn School of Medicine at Mount Sinai. Department of Internal Medicine; Estados Unidoses
uca.affiliationFil: Akinseye, Oluwaseun. Brooklyn College. City University of New York School of Public Health. Estados Unidoses
uca.affiliationFil: Kendzerska, Tetyana. Sunnybrook Health Sciences Center. Institute for Clinical Evaluative Science; Canadaes
uca.affiliationFil: Buttoo, Kenneth. Sleep Disorders Center; Canadaes
uca.affiliationFil: Dhandapany, Perundurai S. Oregon Health and Science University. Departments of Medicine, Molecular and Medical Genetics. Knight Cardiovascular Institute; Estados Unidoses
uca.affiliationFil: Dhandapany, Perundurai S. Institute for Stem Cell Biology and Regenerative Medicine. Centre for Cardiovascular Biology and Disease; Indiaes
uca.affiliationFil: Brown, Gregory M. University of Toronto. Centre for Addiction and Mental Health; Canadaes
uca.affiliationFil: Cardinali, Daniel P. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Instituto de Investigaciones Biomédicas; Argentinaes
uca.affiliationFil: Cardinali, Daniel P. Pontificia Universidad Católica Argentina. Facultad de Ciencias Médicas. Departamento de Docencia e Investigación; Argentinaes
uca.versionsubmittedVersiones
item.grantfulltextopen-
item.fulltextWith Fulltext-
item.languageiso639-1en-
crisitem.author.deptConsejo Nacional de Investigaciones Científicas y Técnicas-
crisitem.author.deptInstituto de Investigaciones Biomédicas - BIOMED-
crisitem.author.deptFacultad de Ciencias Médicas-
crisitem.author.orcid0000-0002-0813-9088-
crisitem.author.parentorgFacultad de Ciencias Médicas-
crisitem.author.parentorgPontificia Universidad Católica Argentina-
Aparece en las colecciones: Artículos
Ficheros en este ítem:
Fichero Descripción Tamaño Formato
melatonin-human-cardiovascular-disease.pdf887,4 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro sencillo del ítem

Visualizaciones de página(s)

174
comprobado en 28-mar-2024

Descarga(s)

150
comprobado en 28-mar-2024

Google ScholarTM

Consultar



Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons